COLL icon

Collegium Pharmaceutical

33.94 USD
+0.73
2.2%
At close Updated Oct 17, 4:00 PM EDT
Pre-market
After hours
33.94
0.00
0%
1 day
2.2%
5 days
5.53%
1 month
-4.5%
3 months
5.21%
6 months
25.66%
Year to date
18.55%
1 year
-12.82%
5 years
66.54%
10 years
77.79%
 

About: Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Employees: 357

0
Funds holding %
of 7,496 funds
0
Analysts bullish %
of 1 analysts
0
Positive news %
of 4 articles
Price charts implemented using Lightweight Charts™